company background image
PROF logo

Profound Medical NasdaqCM:PROF Stock Report

Last Price

US$7.25

Market Cap

US$217.2m

7D

-2.0%

1Y

-20.8%

Updated

20 Dec, 2024

Data

Company Financials +

Profound Medical Corp.

NasdaqCM:PROF Stock Report

Market Cap: US$217.2m

PROF Stock Overview

Operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. More details

PROF fundamental analysis
Snowflake Score
Valuation0/6
Future Growth5/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Rewards

Earnings are forecast to grow 58.94% per year

Risk Analysis

Shareholders have been diluted in the past year


My Notes

Capture your thoughts, links and company narrative

Profound Medical Corp. Competitors

Accuray

NasdaqGS:ARAY

US$180.0m

Nevro

NYSE:NVRO

US$134.5m

KORU Medical Systems

NasdaqCM:KRMD

US$169.6m

Inogen

NasdaqGS:INGN

US$197.9m

Price History & Performance

Summary of share price highs, lows and changes for Profound Medical
Historical stock prices
Current Share PriceCA$7.25
52 Week HighCA$11.42
52 Week LowCA$6.88
Beta0.93
1 Month Change-5.72%
3 Month Change-7.05%
1 Year Change-20.77%
3 Year Change-37.82%
5 Year Change-32.05%
Change since IPO-28.82%

Recent News & Updates

Recent updates

Profound Medical Q2 GAAP EPS beats, revenue in-line

Aug 04

Profound Medical Lacks Conviction To Overthrow Macro Headwinds

Jul 10

Shareholder Returns

PROFUS Medical EquipmentUS Market
7D-2.0%-3.4%-3.5%
1Y-20.8%9.0%22.1%

Return vs Industry: PROF underperformed the US Medical Equipment industry which returned 9% over the past year.

Return vs Market: PROF underperformed the US Market which returned 22.1% over the past year.

Price Volatility

Is PROF's price volatile compared to industry and market?
PROF volatility
PROF Average Weekly Movement7.2%
Medical Equipment Industry Average Movement7.8%
Market Average Movement6.3%
10% most volatile stocks in US Market17.0%
10% least volatile stocks in US Market3.1%

Stable Share Price: PROF has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: PROF's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a131Arun Menawatwww.profoundmedical.com

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors.

Profound Medical Corp. Fundamentals Summary

How do Profound Medical's earnings and revenue compare to its market cap?
PROF fundamental statistics
Market capUS$217.21m
Earnings (TTM)-US$31.39m
Revenue (TTM)US$8.98m

24.0x

P/S Ratio

-6.9x

P/E Ratio

Is PROF overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PROF income statement (TTM)
RevenueUS$8.98m
Cost of RevenueUS$3.41m
Gross ProfitUS$5.57m
Other ExpensesUS$36.96m
Earnings-US$31.39m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-1.05
Gross Margin62.02%
Net Profit Margin-349.41%
Debt/Equity Ratio18.0%

How did PROF perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 02:55
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Profound Medical Corp. is covered by 15 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David KideckelBeacon Securities Limited
Jason MillsCanaccord Genuity
Prakash GowdCIBC Capital Markets